LIMK2
Basic information
Region (hg38): 22:31212239-31280080
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LIMK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 55 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 55 | 2 | 2 |
Variants in LIMK2
This is a list of pathogenic ClinVar variants found in the LIMK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-31225727-T-A | not specified | Uncertain significance (Sep 06, 2022) | ||
22-31225729-T-A | not specified | Uncertain significance (Dec 16, 2022) | ||
22-31225734-A-G | not specified | Uncertain significance (Jun 24, 2022) | ||
22-31225750-G-A | not specified | Uncertain significance (Aug 26, 2024) | ||
22-31225809-T-C | not specified | Uncertain significance (Oct 26, 2022) | ||
22-31225815-T-G | not specified | Uncertain significance (Jun 03, 2022) | ||
22-31248753-T-G | not specified | Uncertain significance (Dec 22, 2023) | ||
22-31259210-G-A | Benign (Jun 01, 2023) | |||
22-31260014-G-A | not specified | Uncertain significance (Apr 22, 2024) | ||
22-31260041-C-G | not specified | Uncertain significance (Jan 30, 2024) | ||
22-31260064-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
22-31262189-C-G | not specified | Uncertain significance (Dec 05, 2024) | ||
22-31262189-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
22-31262216-G-A | not specified | Uncertain significance (Nov 27, 2024) | ||
22-31262655-G-A | not specified | Uncertain significance (Dec 03, 2024) | ||
22-31262679-C-T | not specified | Uncertain significance (May 02, 2023) | ||
22-31262691-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
22-31262692-G-A | not specified | Likely benign (Dec 20, 2023) | ||
22-31262698-C-T | not specified | Uncertain significance (Jul 17, 2024) | ||
22-31262718-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
22-31262730-G-A | not specified | Likely benign (Sep 22, 2023) | ||
22-31262776-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
22-31262781-C-T | not specified | Uncertain significance (Aug 02, 2023) | ||
22-31265995-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
22-31266011-G-A | not specified | Uncertain significance (Sep 21, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LIMK2 | protein_coding | protein_coding | ENST00000340552 | 15 | 67842 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0156 | 0.984 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.40 | 342 | 423 | 0.809 | 0.0000259 | 4503 |
Missense in Polyphen | 68 | 124.49 | 0.54621 | 1397 | ||
Synonymous | -0.114 | 170 | 168 | 1.01 | 0.0000103 | 1341 |
Loss of Function | 3.57 | 9 | 30.2 | 0.298 | 0.00000156 | 355 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000308 | 0.000308 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000480 | 0.0000462 |
European (Non-Finnish) | 0.0000462 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000272 | 0.000261 |
Other | 0.000349 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. {ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:11018042}.;
- Pathway
- Fc gamma R-mediated phagocytosis - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Axon guidance - Homo sapiens (human);Androgen receptor signaling pathway;TGF-beta Signaling Pathway;EGF-EGFR Signaling Pathway;Developmental Biology;Signal Transduction;EPH-Ephrin signaling;EPHB-mediated forward signaling;RHO GTPases Activate ROCKs;RHO GTPase Effectors;Signaling by Rho GTPases;Sema4D induced cell migration and growth-cone collapse;Sema4D in semaphorin signaling;Semaphorin interactions;Axon guidance;CDC42 signaling events;RhoA signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.206
Intolerance Scores
- loftool
- 0.117
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 62.14
Haploinsufficiency Scores
- pHI
- 0.266
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Limk2
- Phenotype
- reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; skeleton phenotype; limbs/digits/tail phenotype; vision/eye phenotype; craniofacial phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype;
Gene ontology
- Biological process
- protein phosphorylation;spermatogenesis;phosphorylation;actin cytoskeleton organization;head development;cornea development in camera-type eye
- Cellular component
- nucleus;cytoplasm;cis-Golgi network
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding;metal ion binding;protein heterodimerization activity